Detailed company information
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 11, 2026
Earnings Transcript for 2026 - Q1Released: May 13, 2026
Earnings Transcript for 2025 - Q4Released: Feb 26, 2026
Earnings Transcript for 2025 - Q3Released: Nov 06, 2025
Earnings Transcript for 2025 - Q2Released: Aug 07, 2025
Earnings Transcript for 2025 - Q1Released: May 13, 2025
Earnings Transcript for 2024 - Q4Released: Feb 27, 2025
Earnings Transcript for 2024 - Q3Released: Nov 06, 2024
Earnings Transcript for 2024 - Q2Released: Aug 08, 2024
Earnings Transcript for 2024 - Q1Released: May 08, 2024
Earnings Transcript for 2023 - Q4Released: Mar 01, 2024
Earnings Transcript for 2023 - Q3Released: Nov 07, 2023
Earnings Transcript for 2023 - Q2Released: Aug 08, 2023
Earnings Transcript for 2023 - Q1Released: May 13, 2023
Earnings Transcript for 2022 - Q4Released: Mar 02, 2023
Earnings Transcript for 2022 - Q3Released: Nov 08, 2022
Earnings Transcript for 2022 - Q2Released: Aug 13, 2022
Earnings Transcript for 2022 - Q1Released: May 06, 2022
Earnings Transcript for 2021 - Q4Released: Feb 28, 2022
Earnings Transcript for 2021 - Q3Released: Nov 09, 2021
Earnings Transcript for 2021 - Q2Released: Aug 12, 2021
Earnings Transcript for 2021 - Q1Released: May 10, 2021
Earnings Transcript for 2020 - Q4Released: Mar 29, 2021
NKTX Nkarta, Inc.
Seer Inc. plans to launch PAS v4 featuring an AI-driven LLM chat interface in late 2026, with a flexible enterprise pricing model supporting large-scale proteomics studies. The announcement highlights strategic innovation and future growth prospects.
Read post
Dafinchi
